3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Renal Cell
5
Neuroendocrine Tumors
3
Neoplasms
3
Tuberous Sclerosis
2
Kidney Neoplasms
2
Breast Neoplasms
2
Angiomyolipoma
2
Waldenstrom Macroglobulinemia
1
Skin Neoplasms
1
Skin Diseases
1
Pancreatic Neuroendocrine Tumors
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lymphoma
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Carcinoma, Large Cell
1
Carcinoma, Hepatocellular
1
Carcinoid Tumor
1
Breast Diseases
1
Interventions
methyl 5-aminolevulinate
1
exemestane
1
Sodium Chloride
1
Fluorouracil
1
Everolimus
1
Botulinum Toxins, Type A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Skin Diseases
×
Everolimus
×
Clear all
NCT01743560
2019-07-18
4EVERUK
Novartis
Phase 4
Completed
52 enrolled
16 charts